The table below shows RESMED INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q3 2026
Q1 2026
Q4 2025
Q3 2025
Q1 2025
Q4 2024
Revenue
$1.41B
$1.43B
$1.42B
$1.34B
$1.29B
$1.28B
Cost of revenue
$544.25M
$540.43M
$544.08M
$514.76M
$525.33M
$530.81M
Gross profit
$870.57M
$890.98M
$878.72M
$820.82M
$766.41M
$751.27M
R&D
$102.86M
$94.27M
$90.97M
$87.32M
$83.94M
$81.37M
RMD annual revenue (10-K history)
RESMED INC reported annual revenue of $5.65B for fiscal year 2026. That is up 9.9% from $5.15B in fiscal 2025. Over the 10 fiscal years shown, annual revenue grew from $2.07B (FY 2017) to $5.65B. Figures come from the company's audited annual reports as filed with the SEC.
